UTILIZATION OF ANTIDIABETIC DRUGS IN HONG-KONG - RELATION TO THE COMMON OCCURRENCE OF ANTIDIABETIC DRUG-INDUCED HYPOGLYCEMIA AMONGST ACUTE MEDICAL ADMISSIONS AND THE RELATIVE PREVALENCE OF NIDDM
Tyk. Chan et al., UTILIZATION OF ANTIDIABETIC DRUGS IN HONG-KONG - RELATION TO THE COMMON OCCURRENCE OF ANTIDIABETIC DRUG-INDUCED HYPOGLYCEMIA AMONGST ACUTE MEDICAL ADMISSIONS AND THE RELATIVE PREVALENCE OF NIDDM, International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 43-46
Antidiabetic drug-induced hypoglycemia as a cause of acute medical adm
issions is more common in Hong Kong (1.7%) than in other countries (0.
1 - 0.5%). To determine if this higher incidence may be related to the
frequent use of some sulphonylureas, we have studied the overall pres
cribing patterns in the public sector in 1994 by reviewing the utiliza
tion of antidiabetic drugs in the general out-patient/general practice
clinics (GOPD) and Hospital Authority public hospitals and affiliated
specialist clinics (HA). The vast majority of patients (90.5%) receiv
ing antidiabetic treat ment were taking sulphonylureas and/or metformi
n, confirming that diabetes mellitus in Hong Kong is predominantly of
the noninsulin-dependent type. The GOPD and the HA each accounted for
approximately half of the sulphonylureas (55% vs 45%) and metformin (4
3% vs 57%) prescribed. Glibenclamide (84.9% vs 79.1%, 83.7% overall) a
nd gliclazide (12.8% vs 16.6%, 14.5% overall) were the 2 most frequent
ly used sulphonylureas. Only 9.5% of patients on antidiabetic drugs we
re receiving insulin and 92% of this was prescribed by the HA. For com
parison, Singapore has a similar prevalence of diabetes mellitus but a
much lower incidence of antidiabetic drug-induced hypoglycemia amongs
t acute medical admissions (0.5%). Tolbutamide was the most frequently
used there sulphonylurea (66.6 - 72.2%) with glibenclamide only contr
ibuting 20.8 - 28.6%. Thus, the predominant use of glibenclamide in Ho
ng Kong may contribute to the high incidence of antidiabetic drug-indu
ced hypoglycemia amongst acute medical admissions.